CD8A and myeloid sarcoma: CD8+ T cell clones are more highly enriched than CD4+ T cells in the blood (1) and cerebrospinal fluid (CSF) (2) of patients with MS and outnumber CD4+ T cells by a factor of 10 in active demyelinating lesions.